Atlas Trials

Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels

Clinical trial NCT00143624 · COMPLETED

Trial details

NCT number
NCT00143624
Sponsor
University of British Columbia
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
AtherosclerosisHIV Infections
Start date
2003-06-01
Primary completion
2009-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.